Literature DB >> 23625489

The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Sandra M Cardona1, Jenny A Garcia, Astrid E Cardona.   

Abstract

The action of chemokines (or "chemotactic cytokines") is recognized as an integral part of inflammatory and regulatory processes. Leukocyte mobilization during physiological conditions, trafficking of various cell types during pathological conditions, cell activation, and angiogenesis are among the target functions exerted by chemokines upon signaling via their specific receptors. Current research is focused in analyzing changes in chemokine/chemokine receptor patterns during various diseases with the aim to modulate pathological trafficking of cells, or to attract particular cell types to specific tissues. This review focuses on defining the role(s) of certain chemokine ligands and receptors in inflammatory neurological conditions such as multiple sclerosis. In addition, the role(s) of chemokines in neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease is also described, as well as the contribution of chemokines to the pathogenesis of cancer, diabetes, and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625489      PMCID: PMC3980472          DOI: 10.1007/978-1-62703-426-5_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  119 in total

1.  Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

Authors:  D H McDermott; J P Halcox; W H Schenke; M A Waclawiw; M N Merrell; N Epstein; A A Quyyumi; P M Murphy
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

2.  Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Authors:  Joseph Kim; Hiroya Takeuchi; Stella T Lam; Roderick R Turner; He-Jing Wang; Christine Kuo; Leland Foshag; Anton J Bilchik; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

3.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

Review 4.  Chemokines in cancer related inflammation.

Authors:  Paola Allavena; Giovanni Germano; Federica Marchesi; Alberto Mantovani
Journal:  Exp Cell Res       Date:  2010-12-04       Impact factor: 3.905

Review 5.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

6.  Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.

Authors:  Eun Young Song; Michael R Shurin; Irina L Tourkova; Dmitriy W Gutkin; Galina V Shurin
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

7.  CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.

Authors:  Taku Kuwabara; Fumio Ishikawa; Takuwa Yasuda; Kentaro Aritomi; Hideki Nakano; Yuriko Tanaka; Yayoi Okada; Martin Lipp; Terutaka Kakiuchi
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

8.  HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.

Authors:  Michael J Chao; Martin C N M Barnardo; Matthew R Lincoln; Sreeram V Ramagopalan; Blanca M Herrera; David A Dyment; Alexandre Montpetit; A Dessa Sadovnick; Julian C Knight; George C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

Review 9.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  18 in total

Review 1.  Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Authors:  Ishan Roy; Douglas B Evans; Michael B Dwinell
Journal:  Surgery       Date:  2014-02-08       Impact factor: 3.982

Review 2.  CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.

Authors:  Guillaume Martin-Blondel; David Brassat; Jan Bauer; Hans Lassmann; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

Review 3.  Chemokines and their receptors: insights from molecular modeling and crystallography.

Authors:  Irina Kufareva
Journal:  Curr Opin Pharmacol       Date:  2016-07-25       Impact factor: 5.547

4.  CXCL12/CXCR4 axis induces proliferation and invasion in human endometrial cancer.

Authors:  Pingping Liu; Ping Long; Yu Huang; Fengyi Sun; Zhenyan Wang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

Review 5.  Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation.

Authors:  Rami A Namas; Qi Mi; Rajaie Namas; Khalid Almahmoud; Akram M Zaaqoq; Othman Abdul-Malak; Nabil Azhar; Judy Day; Andrew Abboud; Ruben Zamora; Timothy R Billiar; Yoram Vodovotz
Journal:  Antioxid Redox Signal       Date:  2015-12-10       Impact factor: 8.401

Review 6.  Caught in the cross fire: p53 in inflammation.

Authors:  Tomer Cooks; Curtis C Harris; Moshe Oren
Journal:  Carcinogenesis       Date:  2014-06-18       Impact factor: 4.944

7.  CXCL13 polymorphism is associated with essential hypertension in Tatars from Russia.

Authors:  Yanina R Timasheva; Timur R Nasibullin; Ilsiyar A Tuktarova; Vera V Erdman; Olga E Mustafina
Journal:  Mol Biol Rep       Date:  2018-07-17       Impact factor: 2.316

Review 8.  Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.

Authors:  Gregory P Takacs; Joseph A Flores-Toro; Jeffrey K Harrison
Journal:  Pharmacol Ther       Date:  2020-12-11       Impact factor: 12.310

Review 9.  Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.

Authors:  Sabrina M de Munnik; Martine J Smit; Rob Leurs; Henry F Vischer
Journal:  Front Pharmacol       Date:  2015-03-09       Impact factor: 5.810

10.  The proangiogenic effect of iroquois homeobox transcription factor Irx3 in human microvascular endothelial cells.

Authors:  Kisha Scarlett; Vaishnavi Pattabiraman; Petrina Barnett; Dong Liu; Leonard M Anderson
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.